contrave

FDA declines to approve Orexigen diet drug (AP)

AP – Orexigen Therapeutics Inc. said Tuesday that U.S. health officials rejected its experimental weight loss pill Contrave and requested a new study of its potential heart risks, suggesting it will be years before a new drug for obesity reaches the market.

See the rest here:
FDA declines to approve Orexigen diet drug
(AP)

contrave

Q & A: How Safe is the Weight-Loss Drug Contrave? (LiveScience.com)

LiveScience.com – A weight-loss drug called Contrave may be approved by the Food and Drug Administration in the coming weeks if the agency follows the advice of one of its panels, which recently weighed in on the matter.

The rest is here:
Q & A: How Safe is the Weight-Loss Drug Contrave?
(LiveScience.com)

contrave

U.S. advisers back first new diet pill in a decade (Reuters)

Reuters – The first new weight-loss pill in a decade moved closer to U.S. approval on Tuesday, when a panel of expert advisers backed Orexigen Therapeutics’s Contrave despite heart risk concerns.

Original post: 
U.S. advisers back first new diet pill in a decade
(Reuters)

contrave

New Diet Pill Wins FDA Panel’s Backing (HealthDay)

HealthDay – TUESDAY, Dec. 7 (HealthDay News) — An expert advisory panel recommended on Tuesday that Contrave, a new weight-loss pill that combines an antidepressant with an anti-addiction medication, be approved by the U.S. Food and Drug Administration.

See the original post: 
New Diet Pill Wins FDA Panel’s Backing
(HealthDay)

contrave

FDA panel recommends approval for Contrave (AP)

AP – A Food and Drug Administration panel on Tuesday recommended that the agency approve Orexigen Therapeutics Inc.’s weight loss drug Contrave, making it the first in group of competitors to get a positive nod from experts.

View post: 
FDA panel recommends approval for Contrave
(AP)

contrave

Orexigen diet pill faces U.S. panel, eyes on safety (Reuters)

Reuters – The last of a trio of new weight loss drugs, Orexigen Therapeutics Inc’s Contrave, is set to face a panel of U.S. advisers on Tuesday who are likely to have tough questions on the pill’s heart risks and other safety concerns.

See the rest here:
Orexigen diet pill faces U.S. panel, eyes on safety
(Reuters)

contrave

Experimental Diet Pill May Bring ‘Modest’ Weight Loss (HealthDay)

HealthDay – FRIDAY, July 30 (HealthDay News) — Contrave, an experimental weight loss drug that combines an antidepressant with an anti-addiction medication, appears to help users shed pounds when taken along with a healthy diet and exercise, researchers report.

View post: 
Experimental Diet Pill May Bring ‘Modest’ Weight Loss
(HealthDay)

contrave

Obese patients lose weight on new Orexigen drug (Reuters)

Reuters – Overweight volunteers who took Orexigen’s experimental drug Contrave, designed to reduce cravings, lost about 13 pounds (6 kg) over a year, U.S. researchers reported on Thursday.

Read more from the original source:
Obese patients lose weight on new Orexigen drug
(Reuters)

contrave

Knee, Hip Replacements May Aid Weight Loss: Study (HealthDay)

HealthDay – THURSDAY, July 29 (HealthDay News) — Weight loss has been noted among patients who’ve had a knee or hip replacement, a new study says.

View original here:
Knee, Hip Replacements May Aid Weight Loss: Study
(HealthDay)

contrave

In Young Girls, Obesity Linked to Early Puberty, Analysis Reveals (HealthDay)

HealthDay – WEDNESDAY, July 28 (HealthDay News) — Obesity is associated with early puberty in young girls, according to a researcher who analyzed more than 100 reports on the issue.

More here:
In Young Girls, Obesity Linked to Early Puberty, Analysis
Reveals
(HealthDay)